Platinum sponsorsWe are grateful to our Platinum sponsors for committing £ 20,000 towards this world Congress. The sponsorship monies will enable EB 2020 to be a truly ground-breaking industry event and to have longevity beyond the four days of Congress. We look forward to working with our sponsors. To find out more about becoming a sponsor please visit our sponsorship opportunities page to see the benefits of sponsoring EB 2020 for your company. Jenny Jackson, Sponsorship Lead would be delighted to talk about tailoring the packages for your company’s needs, please contact Jenny via email@example.com to discuss ways your company can get involved.
Mölnlycke Health CareAt Mölnlycke®, we deliver innovative solutions for managing wounds, improving surgical safety and efficiency, and preventing pressure ulcers. Solutions that help achieve better outcomes and are backed by clinical and health-economics evidence. In everything we do, we are guided by a single purpose: to help healthcare professionals perform at their best. And we’re committed to proving it every day.
Abeona TherapeuticsAbeona Therapeutics is a fully-integrated gene and cell therapy company at the forefront of the rapidly-advancing field of genetic medicine. The company’s multi-platform expertise across research, development, manufacturing and discovery uniquely positions us to bring novel medicines to patients with life-threatening rare diseases.
Amryt PharmaAmryt Pharma is a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases. Amryt Pharma comprises a strong and growing portfolio of commercial and development assets targeting the unmet need in Epidermolysis Bullosa (EB). Amryt Pharma has two products in development for EB:
- Oleogel-S10 (AP101) – a potential topical treatment for the cutaneous manifestations of Recessive & Dystrophic EB, Junctional EB and Kindler Syndrome for which there is currently no approved treatments.
- AP103 – a potential non-viral vector topical gene therapy for patients with Recessive Dystrophic EB.